| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| October 10th, 2004 | 21 | Yes |
1-Butyl- N -(2,4,6-trimethylphenyl)-2-pyrrolidinecarboxamide
1-Butyl-2',4',6'-trimethyl-2-pyrrolidinecarboxanilide
1-Butyl-pyrrolidine-2-carboxylic acid (2,4,6-trimethyl-phenyl)-amide
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | 3.24 | 1.7 | -36.02 | 2 | 3 | 1 | 33 | 289.443 | 5 | ↓ |
| Note Type | Comments | Provided By |
|---|---|---|
| mechanism | Potassium channel (K ATP and K Vol ) blocker | ZereneX Building Blocks |
| biological_use | Antiarrhythmic agent | IBScreen Bioactives |
| biological_use | Local anaesthetic | IBScreen Bioactives IBScreen Bioactives |
| mechanism | Potassium channel (K ATP and K Vol ) blocker | IBScreen Bioactives |
